MYC and pancreatic neoplasm: In pancreatic cancer, elevated levels of the MUC5AC glycoprotein contribute to the disruption of the E-cadherin and β-catenin junction, followed by the nuclear translocation of β-catenin, which ultimately increases MYC expression levels.